13F Holdings
中文EN

HLN Haleon plc IFRS Annual reports only

Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1900304 · Reporting currency GBP · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-1.8%
TTM net income YoY15.6%
TTM EPS YoY17.8%
Revenue 3-yr CAGR0.5%
Net income 3-yr CAGR16.3%

Margins

Gross margin64.2%
Operating margin21.9%
Net margin15.1%
FCF margin21.0%
EBITDA margin25.1%

Returns

ROE10.2%
ROA5.0%
ROIC (approx.)7.9%
Asset turnover0.33x

Leverage & solvency

Liabilities / assets49.5%
Debt / equity0.52x
Current ratio0.92x
Interest coverage7.09x

Cash quality & payout

Operating cash flow / net income1.58x
Accruals ratio-2.9%
Payout ratio36.7%
Capex / revenue2.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: GBP FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue11.03B11.23B11.30B10.86B9.54B
Cost of revenue3.95B4.41B4.55B4.28B3.60B
Gross profit7.08B6.82B6.75B6.58B5.95B
R&D expense316.00M298.00M311.00M300.00M257.00M
SG&A expense4.36B4.45B4.41B4.48B4.09B
Operating income2.41B2.21B2.00B1.82B1.64B
Interest expense340.00M384.00M402.00M258.00M19.00M
Pretax income2.15B1.91B1.63B1.62B1.64B
Income tax472.00M435.00M517.00M499.00M197.00M
Net income1.67B1.44B1.05B1.06B1.39B
EBITDA2.77B2.53B2.31B——
EPS (basic)0.190.160.110.120.15
EPS (diluted)0.180.160.110.120.15
Weighted avg. shares (diluted)9.03B9.18B9.26B9.24B9.23B
Balance sheet
Cash & equivalents1.32B2.25B1.04B684.00M414.00M
Receivables2.06B2.06B1.86B1.88B2.21B
Inventory1.02B1.19B1.41B1.35B951.00M
Current assets4.55B5.72B4.82B4.06B5.25B
PP&E, netmay include right-of-use assets (IFRS)1.87B1.81B1.78B1.76B1.56B
Goodwill8.13B8.20B8.32B8.40B8.25B
Total assets32.63B34.31B34.05B34.81B34.45B
Current liabilities4.93B5.81B4.64B4.37B4.24B
Short-term debt836.00M1.49B656.00M437.00M79.00M
Long-term debt7.77B8.64B8.80B10.00B87.00M
Total debt8.61B10.13B9.46B10.44B166.00M
Total liabilities16.15B18.09B17.33B18.36B7.97B
Shareholders' equity16.43B16.17B16.61B16.33B26.36B
Net debt7.29B7.88B8.41B9.76B-248.00M
Shares outstanding8.95B9.08B9.23B——
Cash flow statement
Operating cash flow2.63B2.30B2.10B2.06B1.36B
Capital expenditure322.00M250.00M234.00M304.00M228.00M
Free cash flow2.31B2.05B1.87B1.76B1.13B
Investing cash flow-346.00M528.00M-134.00M-8.78B-33.00M
Financing cash flow-3.14B-1.54B-1.57B6.91B-1.24B
Depreciation & amortization360.00M324.00M309.00M——
Stock-based compensation86.00M102.00M76.00M15.00M59.00M
Dividends paid612.00M570.00M388.00M2.68B1.15B
Share buybacks——38.00M——

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, GBP, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.